DVS Sciences

San Francisco, United States Founded: 2004 • Age: 22 yrs Acquired By Fluidigm
Novel bioanalytical solutions are manufactured and distributed globally.
Request Access

About DVS Sciences

DVS Sciences is a company based in San Francisco (United States) founded in 2004 was acquired by Fluidigm in January 2014.. DVS Sciences has raised $18.73 million across 2 funding rounds from investors including Pfizer, Fluidigm and Ontario Institute for Cancer Research. DVS Sciences operates in a competitive market with competitors including Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others.

  • Headquarter San Francisco, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $18.73 M (USD)

    in 2 rounds

  • Latest Funding Round
    $14.6 M (USD), Series A

    Jul 14, 2011

  • Investors
    Pfizer

    & 5 more

  • Employee Count
    Employee Count
  • Acquired by
    Fluidigm

    (Jan 29, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of DVS Sciences

DVS Sciences has successfully raised a total of $18.73M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $14.6 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $14.6M
  • First Round

    (11 Feb 2011)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2011 Amount Series A - DVS Sciences Valuation 5AM Ventures , Mohr Davidow Ventures
Feb, 2011 Amount Series A - DVS Sciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in DVS Sciences

DVS Sciences has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Fluidigm and Ontario Institute for Cancer Research. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Venture capital fund backed incubator focused on the healthcare startups
Founded Year Domain Location
Venture capital investments are managed in technology and healthcare sectors by this firm.
Founded Year Domain Location
Corporate-backed venture capital firm focused on the healthcare sector
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by DVS Sciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - DVS Sciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Dvs Sciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of DVS Sciences

DVS Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Beckman Coulter, Blackrock Neurotech, Bruker and Esco Lifesciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of molecular diagnostic testing solutions
domain founded_year HQ Location
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
domain founded_year HQ Location
Medical devices for neurological therapies are developed.
domain founded_year HQ Location
Diversified research instrument systems are manufactured and supplied.
domain founded_year HQ Location
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
domain founded_year HQ Location
Diversified instruments are developed for scientific and laboratory management.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Dvs Sciences

Frequently Asked Questions about DVS Sciences

When was DVS Sciences founded?

DVS Sciences was founded in 2004 and raised its 1st funding round 7 years after it was founded.

Where is DVS Sciences located?

DVS Sciences is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Is DVS Sciences a funded company?

DVS Sciences is a funded company, having raised a total of $18.73M across 2 funding rounds to date. The company's 1st funding round was a Series A of $4.13M, raised on Feb 11, 2011.

What does DVS Sciences do?

DVS Sciences was founded in 2004 in San Francisco, United States. Bioanalytical solutions focused on life sciences are manufactured and distributed worldwide. Operations center on a patented multi-parameter system that includes the CyTOF mass cytometer for quantitative single-cell analysis and MAXPAR reagents featuring stable-isotope-tagged antibodies. Global reach supports research and analytical applications in biotechnology.

Who are the top competitors of DVS Sciences?

DVS Sciences's top competitors include Cepheid, Blackrock Neurotech and Agilent.

Who are DVS Sciences's investors?

DVS Sciences has 6 investors. Key investors include Pfizer, Fluidigm, Ontario Institute for Cancer Research, 5AM Ventures, and Mohr Davidow Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available